What’s the latest on ADT research?

Key sentence from the paper: “All clinical trials of newer agents… in [metastatic castrate-resistant prostate cancer] include patients who maintain castrate levels of testosterone, and so clinical practice should adhere to this principle of continuing ADT when initiating abiraterone, enzalutamide or chemotherapy.

Read More

Does ADT cause dementia?

Key sentence from the paper: “Our study extends previous work supporting an association between use of ADT and Alzheimer disease and suggests that ADT may more broadly affect neurocognitive function.

Read More